Acute and concomitant deterioration of hyponatremia and renal dysfunction associated with heart and liver failure

Clinical Nephrology

Volumn 65, Issue 4, 2006, Pages 248-255

  Hoorn, E J ^a   Lindermans, J ^a   Zietse, R ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Antidiuretic hormone; Diuretics; Neurochumoral response; Renin angiotensin system; Vasopressin receptor antagonists

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYPOTONIC SOLUTION; ISOTONIC SOLUTION; LOOP DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SODIUM; SODIUM CHLORIDE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; URIC ACID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; FATALITY; FEMALE; FLUID THERAPY; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPONATREMIA; INTENSIVE CARE; KIDNEY DYSFUNCTION; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL; TREATMENT WITHDRAWAL; URIC ACID URINE LEVEL; WATER DEPRIVATION;

EID: 33645762295     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP65248     Document Type: Article

References (36)

1. Adrogue HJ, Madias NE 2000 Hyponatremia. N Engl J Med 342: 1581-1589
2. Anderson RJ, Chung HM, Kluge R, Schrier RW 1985 Hyponatremia: A prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med 102: 164-168
3. Arroyo V, Bosch J, Gaya-Beltran J, Kravetz D, Estrada L, Rivera F, Rodes J 1981 Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites. Ann Intern Med 94: 198-201
4. Bataller R, Sort P, Gines P, Arroyo V 1998 Hepatorenal syndrome: Definition, pathophysiology, clinical features and management. Kidney Int Suppl 66: S47-S53
5. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P 2004 Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8: R204-212
6. Brater DC 1998 Diuretic therapy. N Engl J Med 339: 387-395
7. Carvounis CP, Nisar S, Guro-Razuman S 2002 Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int 62: 2223-2229
8. Chung HM, Kluge R, Schrier RW, Anderson RJ 1987 Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med 83: 905-908
9. Dzau VJ, Packer M, Lilly LS, Swartz SL, Hollenberg NK, Williams GH 1984 Prostaglandins in severe congestive heart failure. Relation to activation of the renin angiotensin system and hyponatremia. N Engl J Med 310: 347-352
10. Ellis SJ 1995 Severe hyponatraemia: Complications and treatment. Q J Med 88: 905-909
11. Erasmus RT, Matsha TE 1998 The frequency, aetiology and outcome of severe hyponatraemia in adult hospitalised patients. Cent Afr J Med 44: 154-158
12. Espinel CH, Gregory AW 1980 Differential diagnosis of acute renal failure. Clin Nephrol 13: 73-77
13. Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ 2005 Risk stratification for in-hospital mortality in acutely decompensated heart failure: Classification and regression tree analysis. JAMA 293: 572-580
14. Gerbes AL, Gulberg V, Gines P, Decaux G, Gross P, Gandjini H, Djian J 2003 Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: A randomized double-blind multicenter trial. Gastroenterology 124: 933-939
15. Gheorghiade M, Gattis WA, O'Connor CM, Adams KF, Jr, Elkayam U, Barbagelata A, Ghali JK, Benza RL, McGrew FA, Klapholz M, Ouyang J, Orlandi C 2004 Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: A randomized controlled trial. JAMA 291: 1963-1971
16. Halperin ML, Bichet DG, Oh MS 2001 Integrative physiology of basal water permeability in the distal nephron: Implications for the syndrome of inappropriate secretion of antidiuretic hormone. Clin Nephrol 56: 339-345
17. Henriksen JH, Bendisen F, Gerbes AL, Christensen NJ, Ring-Larsen H, Sorensen TI 1992 Estimated central blood volume in cirrhosis: Relationship to sympathetic nervous activity, beta-adrenergic blockade and atrial natriuretic factor. Hepatology 16: 1163-1170
18. Klahr S, Miller SB 1998 Acute oliguria. N Engl J Med 338: 671-675
19. Kramer BK, Schweda F, Riegger GA 1999 Diuretic treatment and diuretic resistance in heart failure. Am J Med 106: 90-96
20. Lee DS, Austin PC, Rouleau JL, Liu PP Naimark D, Tu JV 2003 Predicting mortality among patients hospitalized for heart failure: Derivation and validation of a clinical model. JAMA 290: 2581-2587
21. Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S 2003 Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: Long-term effects. Am Heart J 145: 459-466
22. Nielsen S, Frokiaer J, Marples D, Kwon TH, Agre P Knepper MA 2002 Aquaporins in the kidney: From molecules to medicine. Physiol Rev 82: 205-244
23. Nolan CR, Anderson RJ 1998 Hospital-acquired acute renal failure. J Am Soc Nephrol 9: 710-718
24. Nzerue CM, Baffoe-Bonnie H, You W, Falana B, Dai S 2003 Predictors of outcome in hospitalized patients with severe hyponatremia. J Natl Med Assoc 95: 335-343
25. Oster JR, Materson BJ 1992 Renal and electrolyte complications of congestive heart failure and effects of therapy with angiotensin-converting enzyme inhibitors. Arch Intern Med 152: 704-710
26. Porcel A, Diaz F, Rendon P, Macias M, Martin-Herrera L, Giron-Gonzalez JA 2002 Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med 162: 323-328
27. Porzio P, Halberthal M, Bohn D, Halperin ML 2000 Treatment of acute hyponatremia: Ensuring the excretion of a predictable amount of electrolyte-free water. Crit Care Med 28: 1905-1910
28. Saeed BO, Beaumont D, Handley GH, Weaver JU 2002 Severe hyponatraemia: Investigation and management in a district general hospital. J Clin Pathol 55: 893-896
29. Schrier RW, Gurevich AK, Cadnapaphornchai MA 2001 Pathogenesis and management of sodium and water retention in cardiac failure and cirrhosis. Semin Nephrol 21: 157-172
30. Shafiee MA, Bohn D, Hoorn EJ, Halperin ML 2003 How to select optimal maintenance intravenous fluid therapy Q J Med 96: 601-610
31. Sonnenblick M, Rosin AJ 1986 Significance of the measurement of uric acid fractional clearance in diuretic-induced hyponatraemia. Postgrad Med J 62: 449-452
32. Spital A 1999 Diuretic-induced hyponatremia. Am J Nephrol 19: 447-452
33. Tamirisa KP, Aaronson KD, Koelling TM 2004 Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure. Am Heart J 148: 971-978
34. Thomas MC 2000 Diuretics, ACE inhibitors and NSAIDs - the triple whammy. Med J Aust 172: 184-185
35. Wong LL, Verbalis JG 2001 Vasopressin V2 receptor antagonists. Cardiovasc Res 51: 391-402
36. Woodrow G, Brownjohn AM, Turney JH 1993 Acute-on-chronic renal failure and hyponatraemia associated with severe hypothyroidism. Nephrol Dial Transplant 8: 557-559